trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT₂ receptor family

Scholarly Works

• Duan, W.; Cao, D.; Wang, S.; Cheng, J. Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. Chemical reviews 2023, 124, 124–163. doi:10.1021/acs.chemrev.3c00375
• Odland, A. U.; Kristensen, J. L.; Andreasen, J. T. Animal Behavior in Psychedelic Research. Pharmacological reviews 2022, 74, 1176–1205. doi:10.1124/pharmrev.122.000590
• Pottie, E.; Stove, C. P. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2A R. Journal of neurochemistry 2022, 162, 39–59. doi:10.1111/jnc.15570
• Rørsted, E. M.; Jensen, A. A.; Kristensen, J. L. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor. ChemMedChem 2021, 16, 3263–3270. doi:10.1002/cmdc.202100395
• Menchikov, L. G.; Shulishov, E. V.; Tomilov, Y. V. Recent advances in the catalytic cyclopropanation of unsaturated compounds with diazomethane. Russian Chemical Reviews 2021, 90, 199–230. doi:10.1070/rcr4982
• Jensen, A. A.; Halberstadt, A. L.; Märcher-Rørsted, E.; Odland, A. U.; Chatha, M.; Speth, N.; Liebscher, G.; Hansen, M.; Bräuner-Osborne, H.; Palner, M.; Andreasen, J. T.; Kristensen, J. L. The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH. Biochemical pharmacology 2020, 177, 113979. doi:10.1016/j.bcp.2020.113979
• Poulie, C. B. M.; Jensen, A. A.; Halberstadt, A. L.; Kristensen, J. L. DARK Classics in Chemical Neuroscience: NBOMes. ACS chemical neuroscience 2019, 11, 3860–3869. doi:10.1021/acschemneuro.9b00528
• Diez-Alarcia, R.; Yáñez-Pérez, V.; Muneta-Arrate, I.; Arrasate, S.; Lete, E.; Meana, J. J.; González-Díaz, H. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [35S]GTPγS Binding Assays. ACS chemical neuroscience 2019, 10, 4476–4491. doi:10.1021/acschemneuro.9b00302
• Saber, I.; Milewski, A.; Reitz, A. B.; Rawls, S. M.; Walker, E. A. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone. Psychopharmacology 2019, 236, 1015–1029. doi:10.1007/s00213-019-05241-z
• Nichols, D. E. Chemistry and Structure–Activity Relationships of Psychedelics. Current topics in behavioral neurosciences 2018, 36, 1–43. doi:10.1007/7854_2017_475
• Jensen, A. A.; McCorvy, J. D.; Leth-Petersen, S.; Bundgaard, C.; Liebscher, G.; Kenakin, T. P.; Bräuner-Osborne, H.; Kehler, J.; Kristensen, J. L. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2, 5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist. The Journal of pharmacology and experimental therapeutics 2017, 361, 441–453. doi:10.1124/jpet.117.239905
• Prabhakaran, J.; Sai, K. K. S.; Zanderigo, F.; Rubin-Falcone, H.; Jorgensen, M. J.; Kaplan, J. R.; Tooke, K. I.; Mintz, A.; Mann, J. J.; Kumar, J. S. D. In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate. Bioorganic & medicinal chemistry letters 2016, 27, 21–23. doi:10.1016/j.bmcl.2016.11.043
• Halberstadt, A. L.; Sindhunata, I. S.; Scheffers, K.; Flynn, A. D.; Sharp, R. F.; Geyer, M. A.; Young, J. W. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology 2016, 107, 364–375. doi:10.1016/j.neuropharm.2016.03.038
• Wang, H.; Zhou, X.; Mao, Y. ASYMMETRIC SYNTHESIS OF CYCLOPROPYLAMINE DERIVATIVES. HETEROCYCLES 2014, 89, 1767–1800. doi:10.3987/rev-14-796

Explore citations to this article at